Thomas W Frazier1, Stelios Georgiades2, Somer L Bishop3, Antonio Y Hardan4. 1. Center for Pediatric Behavioral Health and Center for Autism, Cleveland Clinic. Electronic address: fraziet2@ccf.org. 2. McMaster University and Offord Centre for Child Studies. 3. Center for Autism and the Developing Brain, Weill Cornell Medical College. 4. Stanford University.
Abstract
OBJECTIVE: To examine differences in behavioral symptoms and cognitive functioning between males and females with autism spectrum disorder (ASD). METHOD: We analyzed data from 2,418 probands with autism (304 females and 2,114 males) included in the Simons Simplex Collection. Sex differences were evaluated across measures of autism symptoms, cognitive and motor functioning, adaptive behavior, and associated behavior problems. Measurement bias was examined using latent variable models of symptoms. Unadjusted and propensity-adjusted analyses were computed to ensure that sex differences were not due to unbalanced sampling. Moderator and mediator analyses evaluated whether sex differences were modified by clinical characteristics or were driven by cognitive ability. RESULTS: Females with ASD had greater social communication impairment, lower levels of restricted interests, lower cognitive ability, weaker adaptive skills, and greater externalizing problems relative to males. Symptom differences could not be accounted for by measurement differences, indicating that diagnostic instruments captured autism similarly in males and females. IQ reductions mediated greater social impairment and reduced adaptive behavior in females with ASD, but did not mediate reductions in restricted interests or increases in irritability. CONCLUSIONS: A specific female ASD phenotype is emerging that cannot be accounted for by differential symptom measurement. The present data suggest that the relatively low proportion of high-functioning females may reflect the effect of protective biological factors or may be due to under-identification. Additional carefully accrued samples are needed to confirm the present pattern and to evaluate whether observed sex ratios in high-functioning cases are reduced if female-specific indicators of restricted interests are included.
OBJECTIVE: To examine differences in behavioral symptoms and cognitive functioning between males and females with autism spectrum disorder (ASD). METHOD: We analyzed data from 2,418 probands with autism (304 females and 2,114 males) included in the Simons Simplex Collection. Sex differences were evaluated across measures of autism symptoms, cognitive and motor functioning, adaptive behavior, and associated behavior problems. Measurement bias was examined using latent variable models of symptoms. Unadjusted and propensity-adjusted analyses were computed to ensure that sex differences were not due to unbalanced sampling. Moderator and mediator analyses evaluated whether sex differences were modified by clinical characteristics or were driven by cognitive ability. RESULTS: Females with ASD had greater social communication impairment, lower levels of restricted interests, lower cognitive ability, weaker adaptive skills, and greater externalizing problems relative to males. Symptom differences could not be accounted for by measurement differences, indicating that diagnostic instruments captured autism similarly in males and females. IQ reductions mediated greater social impairment and reduced adaptive behavior in females with ASD, but did not mediate reductions in restricted interests or increases in irritability. CONCLUSIONS: A specific female ASD phenotype is emerging that cannot be accounted for by differential symptom measurement. The present data suggest that the relatively low proportion of high-functioning females may reflect the effect of protective biological factors or may be due to under-identification. Additional carefully accrued samples are needed to confirm the present pattern and to evaluate whether observed sex ratios in high-functioning cases are reduced if female-specific indicators of restricted interests are included.
Authors: Peter Szatmari; Xiao-Qing Liu; Jeremy Goldberg; Lonnie Zwaigenbaum; Andrew D Paterson; Marc Woodbury-Smith; Stelios Georgiades; Eric Duku; Ann Thompson Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2011-11-16 Impact factor: 3.568
Authors: F D Beacher; L Minati; S Baron-Cohen; M V Lombardo; M-C Lai; M A Gray; N A Harrison; H D Critchley Journal: AJNR Am J Neuroradiol Date: 2011-12-15 Impact factor: 3.825
Authors: Felix D C C Beacher; Eugenia Radulescu; Ludovico Minati; Simon Baron-Cohen; Michael V Lombardo; Meng-Chuan Lai; Anne Walker; Dawn Howard; Marcus A Gray; Neil A Harrison; Hugo D Critchley Journal: PLoS One Date: 2012-06-12 Impact factor: 3.240
Authors: Meng-Chuan Lai; Michael V Lombardo; Amber N V Ruigrok; Bhismadev Chakrabarti; Sally J Wheelwright; Bonnie Auyeung; Carrie Allison; Simon Baron-Cohen Journal: PLoS One Date: 2012-10-17 Impact factor: 3.240
Authors: J L Allen; G Oberdorster; K Morris-Schaffer; C Wong; C Klocke; M Sobolewski; K Conrad; M Mayer-Proschel; D A Cory-Slechta Journal: Neurotoxicology Date: 2015-12-22 Impact factor: 4.294
Authors: Chantell Balaan; Michael J Corley; Tiffany Eulalio; Ka'ahukane Leite-Ahyo; Alina P S Pang; Rui Fang; Vedbar S Khadka; Alika K Maunakea; Monika A Ward Journal: Behav Brain Res Date: 2018-08-19 Impact factor: 3.332
Authors: Roald A Øien; Sara M Vambheim; Logan Hart; Anders Nordahl-Hansen; Craig Erickson; Logan Wink; Martin R Eisemann; Frederick Shic; Fred R Volkmar; David Grodberg Journal: J Autism Dev Disord Date: 2018-07
Authors: Emily I White; Gregory L Wallace; Julia Bascom; Anna C Armour; Kelly Register-Brown; Haroon S Popal; Allison B Ratto; Alex Martin; Lauren Kenworthy Journal: Autism Res Date: 2017-06-01 Impact factor: 5.216